An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period

Main Article Content

Andrea Zaenglein
James Del Rosso

Keywords

acne, nodular acne, lidose-isotretinoin, retinoid

Abstract

Abstract not available.

 

Disclosures: Study supported by SUN Pharma.

 

Copyright 2018 SKIN